MedPath

ChangTai Keli

Generic Name
ChangTai Keli

Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients

Phase 2
Conditions
Colon Cancer
Interventions
Drug: mFOLFOX6
Drug: XELOX
Drug: Placebo ChangTai Keli
First Posted Date
2015-07-28
Last Posted Date
2015-08-03
Lead Sponsor
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Target Recruit Count
360
Registration Number
NCT02510118
Locations
🇨🇳

Jiege Huo, Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath